HomeHealth NewsFirst Alzheimer's pill for genetically at high risk shows promise in phase...

First Alzheimer’s pill for genetically at high risk shows promise in phase 3 trial

October 26, 2025

- Advertisement -

A new pill for those genetically at risk for Alzheimer’s has shown benefits in clinical trials. FotografiaBasica/Getty Images

Past studies show that genetics can play an important role in a person’s risk for Alzheimer’s disease.
Previous research reports that the gene variant APOE4 can increase a person’s Alzheimer’s disease risk, and even more so if they have two copies of the gene called APOE4/4.
A new study reports the findings of a Phase 3 clinical trial of the investigational…

- Advertisment -